| For: | Park S, Jeong EJ, Kang JH, Lee GW, Go SI, Lee DH, Koh EH. T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report. World J Clin Cases 2023; 11(26): 6200-6205 [PMID: 37731550 DOI: 10.12998/wjcc.v11.i26.6200] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i26/6200.htm |
| Number | Citing Articles |
| 1 |
Anna Torrent, Vitor Botafogo, Josep Maria Ribera. Leucemia aguda de linaje ambiguo: diagnóstico, pronóstico y tratamiento. Medicina Clínica 2025; 164(12) doi: 10.1016/j.medcli.2025.106917
|
| 2 |
|
| 3 |
Anna Torrent, Vitor Botafogo, Josep Maria Ribera. Acute leukemia of ambiguous lineage: Diagnosis, prognosis and treatment. Medicina Clínica (English Edition) 2025; 164(12) doi: 10.1016/j.medcle.2025.106917
|
| 4 |
Yutian Lei, Xiaoli Zhao, Huijun Huang, Limin Duan, Ji Xu, Kourong Miao, Huihui Zhao, Chun Qiao, Ming Hong, Sixuan Qian, Lei Fan, Yu Zhu. Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia. Therapeutic Advances in Hematology 2026; 17 doi: 10.1177/20406207261480378
|
| 5 |
Mobina Nakhaei Shamahmood, Mohammad Javad Yousefi, Abolfazl Miri, Fatemeh Mezginejad. The combination therapy with venetoclax in therapeutic strategy of acute lymphoblastic leukemia. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-04593-1
|
| 6 |
Ruihua Mi, Shuli Guo, Weidong Yang, Lin Wang, Yixuan Ma, Lin Chen, Dongbei Li, Xudong Wei. Case Report: Venetoclax combined with hypomethylating agents for the treatment of newly diagnosed with mixed-phenotype acute leukemia and a literature review. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1693061
|